Antitumor activity of 4-demethoxydaunorubicin administered orally.
D000284:Administration, Oral; D000818:Animals; D003630:Daunorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D007275:Injections, Intravenous; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D008809:Mice, Inbred C3H; D012510:Sarcoma 180 / Q000188:drug therapy*
D004317:Doxorubicin; D003630:Daunorubicin